"Right now, some women may be making treatment decisions based on incomplete information."
Ninez Ponce, associate Center director, is senior author of a new fact sheet about the use of gene expression profiling, a genomic test that scores an early-stage breast cancer patient's risk of cancer recurrence. In this brief interview, she discusses the test, how test results can be used, and gaps in who receives the test.